Healthcare -
Biotechnology - NASDAQ - US
$ 9.4
5.74 %
$ 796 M
Market Cap
-1.18
P/E
Price Target
Average
222.70%
Revenue Forecast
Estimate
151.54%
EBIT
Estimate
47.70%
Net Income
Estimate
37.41%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Immunome, Inc.
Wall Street analysts predict an average 1-year price target for IMNM of $30.3 , with forecasts ranging from
a
low of
$23 to a high of $35 .
IMNM Lowest Price Target
Wall Street Target
23 USD
144.68%
IMNM Average Price Target
Wall Street Target
30.3 USD
222.70%
IMNM Highest Price Target
Wall Street Target
35 USD
272.34%
REVENUE FORECAST
Revenue Forecast Chart IMNM
EBIT FORECAST
EBIT Forecast Chart IMNM
NET INCOME FORECAST
Net Income Chart IMNM